Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  1997-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.ATV.17.6.1152PMID 9194767
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts

  1996cited by this paper
• Aortic collagen, aortic stiffness, and AT1 receptors in experimental and human hypertension.

  1996cited by this paper
• Angiotensin II-induced growth responses in isolated adult rat hearts. Evidence for load-independent induction of cardiac protein synthesis by angiotensin II.

  1995cited by this paper
• Production of aldosterone in isolated rat blood vessels.

  1995cited by this paper
• Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.

  1994cited by this paper
• Structural remodeling in hypertensive heart disease and the role of hormones.

  1994cited by this paper
• Acute and long‐term effects of angiotensin converting enzyme inhibition on larger arteries and cardiac hypertrophy: mechanical and structural parameters

  1994cited by this paper
• Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension.

  1994cited by this paper
• Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats.

  1994cited by this paper
• Mineralocorticoids, hypertension, and cardiac fibrosis.

  1994cited by this paper
• Flow regulation of vascular tone. Its sensitivity to changes in sodium and calcium.

  1993cited by this paper
• Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.

  1993cited by this paper
• Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension.

  1993cited by this paper
• Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells.

  1992cited by this paper
• Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy.

  1992cited by this paper
• Reactive and reparative myocardial fibrosis in arterial hypertension in the rat.

  1992cited by this paper
• A specific B2‐bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril

  1992cited by this paper
• Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor.

  1992cited by this paper
• Enalapril suppresses normal accumulation of elastin and collagen in cardiovascular tissues of growing rats.

  1992cited by this paper
• Aldosterone-mediated regulation of Na+, K(+)-ATPase gene expression in adult and neonatal rat cardiocytes.

  1991cited by this paper
• Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System

  1991cited by this paper
• Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells

  1991cited by this paper
• Quantitative measurement of fixation rate and dimension changes in the aldehyde/pressure-fixed canine carotid artery.

  1991cited by this paper
• Influence of diuretics on brachial artery diameter and distensibility in hypertensive patients

  1990cited by this paper
• Stimulation of collagen synthesis in fibroblast cultures by a triterpene extracted from Centella asiatica.

  1990cited by this paper
• Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors.

  1989cited by this paper
• Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury.

  1989cited by this paper
• Fibrillar Collagen and Myocardial Stiffness in the Intact Hypertrophied Rat Left Ventricle

  1989cited by this paper
• Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.

  1989cited by this paper
• Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats.

  1987cited by this paper
• Preservation of in vivo morphology of blood vessels for morphometric studies.

  1987cited by this paper
• Arterial effects of aldosterone and antimineralocorticoid compounds mechanism of action.

  1987cited by this paper
• Some effects of aldosterone on sodium kinetics and distribution in porcine arterial wall.

  1983cited by this paper
• Altered arterial ion transport and its reversal in aldosterone hypertensive rat.

  1982cited by this paper
• Quantitative morphology of arterioles from the hamster cheek pouch related to mechanical analysis.

  1982cited by this paper
• Studies on high affinity binding of mineralo- and glucocorticoids in rabbit aorta cytosol.

  1982cited by this paper
• Evidence for an Enhanced Transmembrane Sodium (Na+) Gradient Induced by Aldosterone in the Incubated Rat Tail Artery

  1982cited by this paper
• Effect of Salt on the Vascular Lesions of Spontaneously Hypertensive Rats

  1980cited by this paper
• Is arterial media hypertrophy in spontaneously hypertensive rats a consequence of or a cause for hypertension?

  1980cited by this paper
• Increased collagen synthesis in blood vessels of hypertensive rats and its reversal by antihypertensive agents.

  1974cited by this paper
• Long‐Term Effects of Hypertension on the Rat Aortic Wall and Their Relation to Concurrent Aging Changes: MORPHOLOGICAL AND CHEMICAL STUDIES

  1972cited by this paper
• Hormonal actions of the heart and of lungs on the isolated kidney

  1967cited by this paper
• Blood Vessels

  1959cited by this paper

• Mineralocorticoid Receptor Antagonist Treatment of Established Pulmonary Arterial Hypertension Improves Interventricular Dependence in SU5416-Hypoxia Rat Model.

  2022cites this paper
• Hypertension in chronic kidney disease: What lies behind the scene

  2022cites this paper
• Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects

  2022cites this paper
• Vascular cell-specific roles of mineralocorticoid receptors in pulmonary hypertension

  2021cites this paper
• Coincidence of Large Adrenal Cyst and Prominent Hyporeninemic Hyperaldosteronism

  2021cites this paper
• Investigation of Pathophysiological Aspects of Aortic Growth, Remodeling, and Failure Using a Discrete-Fiber Microstructural Model.

  2020cites this paper
• Endothelial Dysfunction in Primary Aldosteronism

  2019cites this paper
• Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging

  2019cites this paper
• Arterial Stiffness and Blood Pressure during the Aging Process

  2019cites this paper
• Long‐term BP control and vascular health in patients with hyperaldosteronism treated with low‐dose, amiloride‐based therapy

  2019cites this paper
• Cardiovascular risk in primary aldosteronism

  2019cites this paper
• Maintenance of long‐term blood pressure control and vascular health by low‐dose amiloride‐based therapy in hyperaldosteronism

  2019cites this paper
• Smooth Muscle Cell–Mineralocorticoid Receptor as a Mediator of Cardiovascular Stiffness With Aging

  2018cites this paper
• Vascular compliance in women with polycystic ovary syndrome treated with spironolactone

  2018cites this paper
• Primary Aldosteronism and Cerebrovascular Diseases

  2018cites this paper
• Arterial stiffness as a risk factor for clinical hypertension

  2018cites this paper
• Mineralocorticoid receptor blockade improves arginine transport and nitric oxide generation through modulation of cationic amino acid transporter-1 in endothelial cells.

  2018cites this paper
• Regulation of aldosterone in heart failure and vascular aging : implications for therapy

  2017cites this paper
• Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy

  2017cites this paper
• The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall

  2017cites this paper
• Advanced carotid artery disease associated with recurring delirium followed by dementia

  2017cites this paper
• The Link Between Adipose Tissue Renin-Angiotensin-Aldosterone System Signaling and Obesity-Associated Hypertension.

  2017cites this paper
• Hypertensive Cardiovascular Risk: Pulsatile Hemodynamics, Gender, and Therapeutic Implications

  2017cites this paper
• Genomic and rapid effects of aldosterone: what we know and do not know thus far

  2016cites this paper
• Hypertension, Diabetes Type II, and Their Association: Role of Arterial Stiffness.

  2016cites this paper
• Cardiovascular risk markers in patients with primary aldosteronism: A systematic review and meta-analysis of literature studies.

  2016cites this paper
• The two faces of hypertension: role of aortic stiffness.

  2016cites this paper
• Aldosterone Levels, Aortic Stiffness, and Wave Reflection in Essential Hypertensive Patients.

  2015cites this paper
• Implication des cellules Nestin+ dans le remodelage vasculaire en conditions pathologiques

  2015cites this paper
• Role of mineralocorticoid receptor antagonists in cardiovascular disease.

  2015cites this paper
• The effect of aldosterone-antagonist therapy on aortic elastic properties in patients with nonischemic dilated cardiomyopathy

  2015cites this paper
• Microvascular function: disturbed by obesity and rescued by angiotensin blockade.

  2015cites this paper
• Hypertension and chronic kidney disease: respective contribution of mean and pulse pressure and arterial stiffness.

  2015cites this paper
• Role of Metabolic Factors: Lipids, Glucose/Insulin Intolerance

  2015cites this paper
• Spironolactone improves endothelial dysfunction in streptozotocin-induced diabetic rats

  2014cites this paper
• Glucose, Insulin and Potential Strategies of Vascular Stiffening

  2014cites this paper
• Ferrario and Schiffrin Aldosterone Antagonism in Cardiovascular Disease 207

  2014cites this paper
• Exercise in theMetabolic Syndrome

  2014cites this paper
• Endothelial Sodium Channels Trigger Endothelial Salt Sensitivity With Aging

  2014cites this paper
• Treatment of Hypertension and Metabolic Syndrome: Lowering Blood Pressure Is Not Enough for Organ Protection, New Approach-Arterial Destiffening

  2014cites this paper
• Interactive roles of NPR1 gene-dosage and salt diets on cardiac angiotensin II, aldosterone and pro-inflammatory cytokines levels in mutant mice

  2013cites this paper
• Increased Renal Epithelial Na Channel Expression and Activity Correlate With Elevation of Blood Pressure in Spontaneously Hypertensive Rats

  2013cites this paper
• explore the effects of the MR antagonist on disease severity in vivo in two different PH models in two rodent species and on cell biology in vitro in distal bovine PASMCs

  2013cites this paper
• 1 Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension 1 2

  2013cites this paper
• Impact of spironolactone on vascular, myocardial, and functional parameters in untreated patients with a hypertensive response to exercise.

  2013cites this paper
• Spironolactone reduces aortic stiffness via blood pressure-dependent effects of canrenoate

  2013cites this paper
• Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension.

  2013cites this paper
• Chest pain in patients with arterial hypertension, angiographically normal coronary arteries and stiff aorta: the aortic pain syndrome.

  2013cites this paper
• Vascular mineralocorticoid receptors regulate blood pressure effects on myogenic tone and role in aging.

  2013cites this paper
• Long‐term application of the aldosterone antagonist spironolactone prevents stiff endothelial cell syndrome

  2013cites this paper
• Exercise in the Metabolic Syndrome

  2012cites this paper
• Regulation of aortic extracellular matrix synthesis via noradrenergic system and angiotensin II in juvenile rats

  2012cites this paper
• The mineralocorticoid receptor-p38MAPK-NFκB or ERK-Sp1 signal pathways mediate aldosterone-stimulated inflammatory and profibrotic responses in rat vascular smooth muscle cells

  2012cites this paper
• Vascular Actions of Aldosterone

  2012cites this paper
• Arterial Stiffness and Stroke in Hypertension Therapeutic Implications for Stroke Prevention

  2012cites this paper
• EGb 761 promotes osteoblastogenesis, lowers bone marrow adipogenesis and atherosclerotic plaque formation.

  2012cites this paper
• Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels.

  2011cites this paper
• Proteins mediating collagen biosynthesis and accumulation in arterial repair: novel targets for anti-restenosis therapy.

  2011cites this paper
• Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension.

  2011cites this paper
• Relations between large artery structure and function and aldosterone.

  2011cites this paper
• Role of cellular mechanics in the function and life span of vascular endothelium

  2011cites this paper
• Pre-clinical data on the role of mineralocorticoid receptor antagonists in reversing vascular inflammation

  2011cites this paper
• L’hypertension artérielle et les désordres vasculaires induits par l'érythropoïétine recombinante humaine et le système rénine-angiotensine-aldostérone : Effet de l’exercice et des cellules T régulatrices

  2011cites this paper
• Aldosterone and inflammation

  2010cites this paper
• Aldosterone: effects on the kidney and cardiovascular system

  2010cites this paper
• Aldosterone receptor inhibition alters the viscoelastic biomechanical behavior of the aortic wall

  2010cites this paper
• Critical appraisal of the differential effects of antihypertensive agents on arterial stiffness

  2010cites this paper
• Hypertension and dyslipidemia in the pathophysiology of chronic kidney disease

  2009cites this paper
• CHANGES IN THE COMPOSITION OF THE THORACIC AORTIC WALL IN SPONTANEOUSLY HYPERTENSIVE RATS TREATED WITH LOSARTAN OR SPIRONOLACTONE

  2009influential citation
• Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt.

  2009cites this paper
• Low-Dose Spironolactone: Effects on Artery-to-Artery Vein Grafts and Percutaneous Coronary Intervention Sites

  2009cites this paper
• Aldosterone activates endothelial exocytosis

  2009cites this paper
• Central aortic stiffness in patients with nonischemic dilated cardiomyopathy: relationship with neurohumoral activation.

  2009cites this paper
• Eplerenone Decreases Inflammatory Foci in Spontaneously Hypertensive Rat Hearts With Minimal Effects on Blood Pressure

  2009cites this paper
• Aldosterone and vascular inflammation.

  2008cites this paper
• Rôles physiopathologiques des récepteurs corticostéroïdes dans le rein et dans l'endothélium vasculaire : apports des modèles conditionnels transgéniques

  2008cites this paper
• Aldostérone, dysfonction endothéliale et maladies cardiovasculaires

  2008cites this paper
• Adrenalectomy improves arterial stiffness in primary aldosteronism.

  2008cites this paper
• Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR.

  2007cites this paper
• Carotid atherosclerosis, arterial stiffness and stroke events.

  2007cites this paper
• To what extent can coronary calcification and arterial stiffness be influenced by the nephrologist?

  2007cites this paper
• Animal models of arterial stiffness.

  2007cites this paper
• Altered collagen homeostasis in human aortic smooth muscle cells (HAoSMCs) induced by aldosterone

  2007cites this paper
• Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats

  2007cites this paper
• Causes and Consequences of Increased Arterial Stiffness in Chronic Kidney Disease Patients

  2007cites this paper
• Aldosterone antagonism fails to attenuate age-associated left ventricular fibrosis.

  2007cites this paper
• Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of spironolactone and losartan regarding long-term blood pressure and target organ damage

  2007cites this paper
• Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats.

  2007cites this paper
• Atherosclerosis, arterial stiffness and antihypertensive drug therapy.

  2007cites this paper
• Influence of Sodium on Pulse Pressure and Systolic Hypertension in the Elderly

  2007cites this paper
• Addition of spironolactone to an angiotensin-converting enzyme inhibitor decreases lung congestion and edema in Dahl hypertensive rats

  2006cites this paper
• [Modern antihypertensive therapy in the light of arterial vascular function].

  2006cites this paper
• Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy.

  2006cites this paper
• Eplerenone suppresses neointimal formation after coronary stent implantation in swine.

  2006cites this paper
• Moderne antihypertensive Therapie im Licht der arteriellen Gefäßfunktion Antihypertensive therapy and arterial function

  2006cites this paper
• Aldosterone and large artery vessels.

  2006cites this paper
• Combined Effects of Low‐Dose Spironolactone and Captopril Therapy in a Rat Model of Genetic Hypertrophic Cardiomyopathy

  2006cites this paper
• Elastic fibres and vascular structure in hypertension.

  2006cites this paper
• Differences Between Cardiac and Arterial Fibrosis and Stiffness in Aldosterone-Salt Rats: Effect of Eplerenone

  2006cites this paper
• THE ROLE OF ANGIOTENSIN-(1-7) IN CARDIOVASCULAR PHYSIOLOGY

  2006cites this paper